Kohta Miyawaki

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients.

Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients.

Journal: Cancer science

Published: March 05, 2026

Early prediction of ICANS using CRS characteristics in B-cell lymphoma patients receiving CAR-T therapy.

Early prediction of ICANS using CRS characteristics in B-cell lymphoma patients receiving CAR-T therapy.

Journal: International journal of hematology

Published: February 25, 2026

p62/SQSTM1 Accumulation Defines an Epithelial-Mesenchymal Transition (EMT)/Twist1-Associated Infiltrative Phenotype in Pancreatic Neuroendocrine Tumors.

p62/SQSTM1 Accumulation Defines an Epithelial-Mesenchymal Transition (EMT)/Twist1-Associated Infiltrative Phenotype in Pancreatic Neuroendocrine Tumors.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: January 29, 2026

Tumor Microenvironments in Malignant Ovarian Germ Cell Tumors: MHC Class I Loss and T-Cell Exhaustion in Dysgerminoma.

Tumor Microenvironments in Malignant Ovarian Germ Cell Tumors: MHC Class I Loss and T-Cell Exhaustion in Dysgerminoma.

Journal: Cancer science

Published: August 21, 2025

Safety and effectiveness of lisocabtagene maraleucel following PD-1 blockade in relapsed or refractory PMBCL.

Safety and effectiveness of lisocabtagene maraleucel following PD-1 blockade in relapsed or refractory PMBCL.

Journal: International journal of hematology

Published: August 01, 2025

Preliminary analysis of a multicenter study of Pola-R-CHP in untreated Japanese patients with DLBCL (POLASTAR).

Preliminary analysis of a multicenter study of Pola-R-CHP in untreated Japanese patients with DLBCL (POLASTAR).

Journal: International journal of hematology

Published: July 24, 2025

Engraftment syndrome after PD-1 blockade in classical Hodgkin lymphoma treated by autologous stem cell transplantation.

Engraftment syndrome after PD-1 blockade in classical Hodgkin lymphoma treated by autologous stem cell transplantation.

Journal: International journal of hematology

Published: June 22, 2025

Burkitt in disguise: clonal transformation of incidentally detected gallbladder diffuse large B-cell lymphoma in a liver transplant recipient.

Burkitt in disguise: clonal transformation of incidentally detected gallbladder diffuse large B-cell lymphoma in a liver transplant recipient.

Journal: International journal of hematology

Published: May 28, 2025

Objective quantification of pre-CAR-T EEG abnormalities for ICANS prognosis: insights from GTE scoring.

Objective quantification of pre-CAR-T EEG abnormalities for ICANS prognosis: insights from GTE scoring.

Journal: Bone marrow transplantation

Published: February 22, 2025

The effective and safe administration of Epcoritamab in relapsed CD19-CD5+ DLBCL following CAR-T therapy.

The effective and safe administration of Epcoritamab in relapsed CD19-CD5+ DLBCL following CAR-T therapy.

Journal: Blood cell therapy

Published: December 23, 2024

Indirect presentation of mismatched human leukocyte antigen-B associates with outcomes of cord blood transplantation.

Indirect presentation of mismatched human leukocyte antigen-B associates with outcomes of cord blood transplantation.

Journal: British journal of haematology

Published: November 15, 2024

Cerebrospinal fluid proteomics exerts predictive potential for immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR-T cell therapy.

Cerebrospinal fluid proteomics exerts predictive potential for immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR-T cell therapy.

Journal: Leukemia

Published: September 01, 2024

Showing 1-12 of 63

Last Updated: 09/26/2026